Search

everythinglearnresearchcommunity

for

Search:↓

Chemotherapy worsens nutritional status in breast cancer patients, requiring targeted nutritional strategies.

PRP treatment may help improve hair density and thickness in breast cancer patients with therapy-induced hair loss.

Ongoing follow-up and dietary counseling are crucial for maintaining health benefits after metabolic surgery.

Successful outcomes depend on accurate diagnosis and strong doctor-patient relationships.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Different types of persistent hair loss after chemotherapy respond differently to treatments.

Alopecia treatments like 5α-reductase inhibitors and spironolactone are safe for breast cancer patients and high-risk women.

Patients with HR+/HER2- advanced breast cancer commonly experience fatigue, hair loss, and pain, which significantly affect daily activities.

Scalp cooling effectively reduces hair loss in breast cancer patients undergoing chemotherapy.

The new device improves surgical accuracy by using a special dye and camera to see inside tissues.

HER2-targeted or hormonal therapies improve quality of life for Sudanese breast cancer patients.

Honey and bee pollen can help reduce menopausal symptoms in breast cancer patients.

Madarosis (eyebrow and eyelash loss) significantly affects quality of life for breast cancer patients on taxane-based chemotherapy.

Oral dutasteride, minoxidil, and finasteride may help reduce hair loss in breast cancer survivors, but more research is needed.

Consult an oncologist before using supplements for hair loss during breast cancer treatment.

Eribulin-based chemotherapy is more effective and has fewer side effects for advanced triple-negative breast cancer.

A specific hair protein variant increases the spread of breast cancer and is linked to worse survival rates.

Neoadjuvant endocrine therapy led to a better future outlook than chemotherapy, with no major quality of life differences.

Epirubicin and cyclophosphamide cause more anemia and side effects than docetaxel and cyclophosphamide, but both are equally effective.

Chemotherapy reduces taste and smell, but they mostly recover after treatment; adding spices may help improve appetite.

Nanofat shows promise for facial rejuvenation and treating skin issues but needs more research for long-term safety.

Comprehensive information and trained nurses are crucial for a better scalp cooling experience during chemotherapy.

Patients and oncologists prioritize survival benefits, while payers focus on treatment costs.

CCCA affects adolescents too, with genetic and environmental links, requiring careful diagnosis.

Finasteride can cause one-sided breast enlargement, which disappears after stopping the drug.

Hormone treatment for transsexual individuals is effective but carries risks like thromboembolic events and mood changes, with most side effects being minor and reversible.

Secondary aesthetic surgeries for gender reassignment are generally satisfying and advance overall aesthetic surgery techniques, but psychological support is important.

Chemotherapy causes temporary hair loss in women, while Tamoxifen does not significantly affect hair, and genetics show no link between female pattern hair loss and common baldness genes.

Aesthetic surgery improves body image and mental health, but pre-surgery psychological screening is important to manage expectations.

Hormone treatment for transgender patients may not need to be stopped before surgery, but more research is needed, especially on estrogen.